Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000519849 | SCV000617974 | pathogenic | not provided | 2016-01-07 | criteria provided, single submitter | clinical testing | The c.4011+1 G>A pathogenic variant in the COL7A1 gene has not been reported previously in association with DEB to our knowledge, however numerous other splicing mutations have been reported in the canonical splice sequence.. This splice site variant destroys the canonical splice donor site in intron 33. It is predicted to cause abnormal gene splicing, either leading to an abnormal message that is subject to nonsense-mediated mRNA decay, or to an abnormal protein product if the message is used for protein translation. The c.4011+1 G>A variant was not observed in approximately 6500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. We interpret c.4011+1 G>A as a pathogenic variant. |
Center for Research in Genodermatoses and Epidermolysis Bullosa, |
RCV002279312 | SCV002499331 | pathogenic | Recessive dystrophic epidermolysis bullosa | 2022-03-14 | criteria provided, single submitter | clinical testing |